[{"Assets_0_Q3_USD":1339644000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":67701000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":68621000.0,"StockholdersEquity_0_Q3_USD":870527000.0,"RevenuesConverted_3_Q3_USD":42943000.0,"RevenuesConverted_1_Q3_USD":22677000.0,"NetIncomeLossConverted_1_Q3_USD":-216816000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":68621000.0,"NetIncomeLossConverted_3_Q3_USD":-664326000.0,"EarningsPerShareDiluted_3_Q3_USD":-9.81,"EarningsPerShareDiluted_1_Q3_USD":-3.16,"EarningsPerShareBasic_3_Q3_USD":-9.81,"EarningsPerShareBasic_1_Q3_USD":-3.16,"CommonStockSharesOutstanding_0_Q3_shares":70097000.0,"CommonStockSharesConverted_0_Q3_shares":70097000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-495914000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":67701000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]